Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06238128 · ClinicalTrials.gov registry record · NA

Opioid Rapid Response System: Naloxone Training in Communities

A NA study of Opioid Overdose, sponsored by University of Missouri-Columbia.

Completed
Registry status
NA
Development phase
773
Enrollment target
1
Study location

NCT06238128: Completed NA study of Opioid Overdose, sponsored by University of Missouri-Columbia.

NCT06238128 is a NA study of Opioid Overdose that has completed, run by University of Missouri-Columbia. The registered enrollment target is 773 participants, below the 4,146-participant average among 8 other Opioid Overdose trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06238128, a NA study of Opioid Overdose, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
NA
Development phase
773 participants
Enrollment target
1
Study location

Study Summary

The pervasive impact of the opioid epidemic has touched all layers of society for the past two decades, resulting in over 115 deaths daily and imposing annual costs of $78.5 billion. Responding swiftly to overdoses, akin to various medical emergencies, poses a significant challenge, particularly in geographically dispersed rural areas and densely populated urban settings. Effectively delivering the life-saving drug naloxone, which counteracts the effects of overdoses, necessitates a well-coordinated and cost-efficient response system. Simply opting for widespread distribution of naloxone, even with citizen involvement, proves to be a financially burdensome approach when compared to more targeted strategies. Moreover, obstacles such as limited access, inadequate or unavailable naloxone training, and delayed response times from emergency responders compound the problem. Addressing these issues, the proposed Opioid Rapid Response System (ORRS) project seeks to advance prevention science by adopting an innovative approach that incorporates technology and contemporary communication theory. The primary objective of the ORRS project is to mitigate opioid overdose deaths by enlisting and training citizens to administer naloxone in response to such events. Leveraging the PulsePoint health app, which connects citizens to cardiac events, the ORRS project will extend its capabilities to respond to overdose incidents. This initiative involves comprehensive development of ORRS, followed by a randomized clinical trial on a national scale to assess its effectiveness. The study aims to contribute to both prevention and implementation science by identifying optimal recruitment strategies and testing a model of online training. In pursuit of these objectives, the study is guided by the following Specific Aims: SA 1: Refine and complete the development of ORRS. SA 2: Conduct a randomized clinical trial to evaluate the effectiveness of the intervention. SA 3: Prepare ORRS for dissemi

Primary Outcome

Investigators will use a subset of Opioid Overdose Knowledge Scale (OOKS) to measure through a forced choice scale with each choice coded as correct (=1) or incorrect (=0). Higher score indicated greater knowledge of overdose sign.

Conditions Studied

Interventions

  • BEHAVIORAL Opioid Rapid Resonse System (ORRS) training
  • BEHAVIORAL Non-active opioid overdose response training

Study Locations (1)

California

  • Ewald & Wasserman Research Consultants, LLC - San Francisco

Trial Details

FieldValue
Enrollment Target 773 participants
Start Date 2024-05-24
Est. Completion 2025-12-29
Phase NA
University of Missouri-Columbia

291 total trials

What the finished NCT06238128 record still lists

NCT06238128 is an interventional study that assigns participants to a tested intervention. The registered 773 participants enrollment target is mid-sized for trials with a published cap, below the 4,146-participant average among 8 other Opioid Overdose trials with a reported enrollment target (81% lower).

The record links to 1 condition, with Opioid Overdose appearing as the primary indexed condition, and to 2 interventions - of which Opioid Rapid Resonse System (ORRS) training is the first listed.

NCT06238128 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06238128 about?

NCT06238128 is a clinical study titled "Opioid Rapid Response System: Naloxone Training in Communities". The pervasive impact of the opioid epidemic has touched all layers of society for the past two decades, resulting in over 115 deaths daily and imposing annual costs of $78.5 billion. Responding swiftly to overdoses, akin to various medical emergencies, poses a significant challenge, particularly in ...

What is the current status of trial NCT06238128?

This trial is currently completed. It is a NA study. The enrollment target is 773 participants. The study started on 2024-05-24. Estimated completion is 2025-12-29.

What conditions does trial NCT06238128 study?

This clinical trial studies the following conditions: Opioid Overdose.

What interventions are being tested in trial NCT06238128?

The interventions under investigation include: Opioid Rapid Resonse System (ORRS) training (BEHAVIORAL), Non-active opioid overdose response training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06238128?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06238128 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Overdose

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06238128's enrollment target sits among peer trials

773 4th of 8 higher than 5 of 8 other Opioid Overdose trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Overdose trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03460769 · 775 participants

    Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

  • NCT06145763 · 776 participants · NA

    A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial

  • NCT05977348 · 770 participants · NA

    Increasing Food Literacy in Preschoolers to Reduce Obesity Risk

  • NCT06376994 · 770 participants · Phase 3

    Multi-Center Clean Air Randomized Controlled Trial in COPD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06238128, the US trial registry maintained by the National Library of Medicine. NCT06238128 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.